DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Boehringer Ingelheim
Zai Lab (Hong Kong), Ltd.
Hoffmann-La Roche
Akeso
Bristol-Myers Squibb
Daiichi Sankyo
AstraZeneca
Amgen
Amgen
Hoffmann-La Roche
BioNTech SE
Hoffmann-La Roche
Norwegian University of Science and Technology
AbbVie
Shanghai Henlius Biotech
Amgen
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Amgen
Shanghai Henlius Biotech
AstraZeneca
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Merck Sharp & Dohme LLC
Instituto de Investigación Biomédica de Salamanca
NRG Oncology
SWOG Cancer Research Network
AstraZeneca
Changchun GeneScience Pharmaceutical Co., Ltd.
BeiGene
Ipsen
MediLink Therapeutics (Suzhou) Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Alliance for Clinical Trials in Oncology
Shanghai Junshi Bioscience Co., Ltd.
Luye Pharma Group Ltd.
Chipscreen Biosciences, Ltd.
Peking University Cancer Hospital & Institute
EpicentRx, Inc.
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Hoffmann-La Roche
Jiangsu Simcere Pharmaceutical Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
EpicentRx, Inc.
Luye Pharma Group Ltd.
Advenchen Laboratories, LLC
Lee's Pharmaceutical Limited
Hoffmann-La Roche
National Cancer Institute, Naples
Merck Sharp & Dohme LLC